Correspondence in reference to previously published manuscript: "Faouzi Djebbari et al. Efficacy and infection morbidity of front-line immuno-chemotherapy in follicular lymphoma. Eur J Haematol. 2020; 105: 667-671"

Eur J Haematol. 2021 May;106(5):734-736. doi: 10.1111/ejh.13558. Epub 2021 Mar 2.
No abstract available

Keywords: antimicrobial prophylaxis; bendamustine; indolent lymphoma; rituximab.

Publication types

  • Letter
  • Comment

MeSH terms

  • Bendamustine Hydrochloride
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell*
  • Lymphoma, Follicular* / diagnosis
  • Lymphoma, Follicular* / drug therapy
  • Morbidity

Substances

  • Bendamustine Hydrochloride